Peripheral nervous system cancer
diseaseOn this page
Also known as cancer of peripheral nervous systemmalignant neoplasm of peripheral nervemalignant neoplasm of peripheral nervous systemmalignant neoplasm of PNSmalignant neoplasm of the peripheral nervemalignant neoplasm of the peripheral nervous systemmalignant neoplasm of the PNSmalignant neoplasms, peripheral nervemalignant peripheral nerve neoplasmmalignant peripheral nerve tumormalignant peripheral nerve tumourmalignant peripheral nervous system neoplasmmalignant peripheral nervous system tumormalignant peripheral nervous system tumourmalignant PNS neoplasmmalignant PNS tumormalignant PNS tumourmalignant tumor of peripheral nervemalignant tumor of peripheral nervous systemmalignant tumor of PNS
Summary
Peripheral nervous system cancer (MONDO:0021089) is a cancer (an umbrella term covering 18 Mondo subtypes). A subtype of peripheral nervous system neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Classification: Cancer
- Umbrella term: 18 Mondo subtypes
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | peripheral nervous system cancer |
| Mondo ID | MONDO:0021089 |
| NCIT | C4961 |
| SNOMED CT | 254986007 |
| UMLS | C0751428 |
| MedGen | 155556 |
| Anatomy (UBERON) | UBERON:0000010 |
| Is cancer (heuristic) | yes |
Also known as: cancer of peripheral nervous system · malignant neoplasm of peripheral nerve · malignant neoplasm of peripheral nervous system · malignant neoplasm of PNS · malignant neoplasm of the peripheral nerve · malignant neoplasm of the peripheral nervous system · malignant neoplasm of the PNS · malignant neoplasms, peripheral nerve · malignant peripheral nerve neoplasm · malignant peripheral nerve tumor · malignant peripheral nerve tumour · malignant peripheral nervous system neoplasm · malignant peripheral nervous system tumor · malignant peripheral nervous system tumour · malignant PNS neoplasm · malignant PNS tumor · malignant PNS tumour · malignant tumor of peripheral nerve · malignant tumor of peripheral nervous system · malignant tumor of PNS (+11 more)
Disease family
This is a subtype of peripheral nervous system neoplasm. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › nervous system disorder › peripheral nervous system disorder › peripheral nervous system neoplasm › peripheral nervous system cancer
Related subtypes (8): autonomic nervous system neoplasm, nerve sheath neoplasm, cranial nerve neoplasm, mediastinal neural neoplasm, nerve plexus neoplasm, nerve root neoplasm, peripheral ganglioneuroblastoma, benign neoplasm of peripheral nervous system
Subtypes (18): mediastinum neuroblastoma, malignant cranial nerve neoplasm, granular cell cancer, neurofibroma of gallbladder, adrenal gland ganglioneuroblastoma, malignant carotid body paraganglioma, neurofibroma of the heart, ganglioneuroma, malignant adrenal gland pheochromocytoma, malignant jugulotympanic paraganglioma, pheochromocytoma/paraganglioma syndrome 2, pheochromocytoma/paraganglioma syndrome 5, malignant perineurioma, malignant peripheral nerve sheath tumor, peripheral primitive neuroectodermal tumor, malignant mediastinal neural neoplasm, isolated melanotic schwannoma, cauda equina cancer
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.